Icure Pharmaceutical Incorporation (175250) Stock Overview

Icure Pharmaceutical Incorporation, a biopharmaceutical company, researches, develops, and sells pharmaceutical and cosmetic products in South Korea. The company offers transdermal and intradermal drug delivery systems; functional, nature-derived, derma, and customized cosmetics products; eye gel, hydro nude gel, lip gel mask, and functional patch products; and sheet, mud, foil, and melting masks. It also provides body and haircare products, including naturally derived hair and body care, baby skin, and wet wipes and cleansing tissue products; and perfumes, textile perfumes, body mists, and hair and body fragrances. The company was founded in 2000 and is headquartered in Seoul, South Korea.